Dr Anup Rawool, Consultant in Clinical and Cancer Genetics at Sahyadri Hospitals, Pune, discusses innovative therapies and ...

Mick had a major operation to treat pancreatic cancer in 2023. Diana wrote to BBC News explaining that it is impossible for Mick to digest food without creon. She says he was prescribed a high dose to ...

Sangamo Therapeutics Inc (SGMO) reports significant progress in its Fabry disease program and neurology therapies, while ...

Discover the top common causes of yellow poop, including health conditions and dietary changes, according to a gastroenterologist. Plus, how to prevent yellow poop from happening.

Raymond James analyst Ryan Deschner lowered the firm’s price target on Inozyme (INZY) to $12 from $24 and keeps an Outperform rating on the ...

Given that there is now an enzyme replacement therapy available to treat hypophosphatasia, its early diagnosis is ...

Amicus Therapeutics benefits from strong revenue and limited competition. Learn why FOLD stock is a BUY, with a favorable ...

Creon, a pancreatic enzyme replacement therapy (Pert), helps digestion, but has been hard to obtain for the last year and shortages are predicted to last until 2026. It is thought more than 61,000 ...

the general pediatric population. The prevalence of food allergy significantly differed by sex and pancreatic enzyme replacement therapy. SAN DIEGO — In a cohort of nearly 300 pediatric patients ...

We recently published a list of Paul Singer’s Latest Portfolio: Top 10 Stock Picks. In this article, we are going to take a ...

Fatty pancreas disease, characterized by intra-pancreatic fat deposition, is more prevalent than diabetes, pancreatitis, and ...